Ovarian Cancer Canada

Ovarian Cancer Canada We will not rest until women are able to live their lives freely, uninhibited by ovarian cancer.
(1)

08/20/2026

✨ THE LADY BALL Calgary, presented by Keyera, is BACK and better than ever! ✨

THE LADY BALL made its grand return to Calgary in 2025 and is back again this year! Join us on Thursday, October 22 for a night you’ll never forget. After last year’s sold-out event, it’s back by popular demand at a brand-new, larger venue: Hyatt Regency Calgary. Alberta, pop the bubbly and spread the word!

Get your tickets now: https://secure.ovariancanada.org/site/Ticketing?view=Tickets&id=103731&s_promoCode=REGULAR

While celebrating the women living with ovarian cancer, every dollar raised directly contributes to advancing ovarian cancer research, supporting those impacted by the disease, and spreading awareness. Filled with fashion, food, fun and endless entertainment, don’t miss your chance to make a real difference while enjoying an unforgettable evening!

Today, Canadians in are sharing their voices to break barriers that limit access to critical cancer treatment, ELAHERE (...
08/14/2026

Today, Canadians in are sharing their voices to break barriers that limit access to critical cancer treatment, ELAHERE (mirvetuximab soravtansine). Join us in demanding action for Canadian women.

This therapy represents a critical advancement for Canadians facing FRα-positive, platinum-resistant ovarian cancer, because standard chemotherapy is no longer a viable treatment option for these women. It is the first major treatment update this group has seen in over a decade.

This is your moment to join them and make this breakthrough accessible to those who need it most.

🔔 CONTEST ALERT 🔔From August 11–31, 2026, every new   team member earns a chance to win a Lunch and Learn for their team...
08/11/2026

🔔 CONTEST ALERT 🔔

From August 11–31, 2026, every new team member earns a chance to win a Lunch and Learn for their team, featuring an ovarian cancer expert!

TO ENTER:
🔹 Register for the 2026 Ovarian Cancer Canada Walk of Hope as a member of a team
🔹 Raise or self-donate $25 or more

Whether you're walking with friends, family, coworkers, or neighbours, you'll be helping fund life-changing ovarian cancer research, advocacy, and support for everyone affected by the disease.

🔗 Join a team and make your $25 self-donation now: https://secure.ovariancanada.org/site/TR?fr_id=2241&pg=entry&s_locale=en_CA&utm_source=facebook&utm_medium=social&utm_campaign=walk&utm_content=teamcontest

Contest runs August 11–31, 2026. Open to registered participants of the 2026 Ovarian Cancer Canada Walk of Hope. See full contest rules for details.

Are you or a loved one facing an endometrial cancer diagnosis? We're answering the most commonly asked questions people ...
07/31/2026

Are you or a loved one facing an endometrial cancer diagnosis? We're answering the most commonly asked questions people have when they're diagnosed:

🔹 What is endometrial cancer?
🔹 What are the warning signs?
🔹 How is endometrial cancer treated?
🔹 Can it be cured?
🔹 What are the risk factors?
🔹 How can endometrial cancer be prevented?

Hear from Alison Ross, Ovarian Cancer Canada's Director of Knowledge Mobilization, as she share vital information on the disease in our latest video: https://youtu.be/rSTPGTbAURU

The process to make a new innovative ovarian cancer treatment accessible in Canada has stalled. We are demanding provinc...
07/30/2026

The process to make a new innovative ovarian cancer treatment accessible in Canada has stalled.

We are demanding provincial and territorial decision-makers to restart critical negotiations for ELAHERE (mirvetuximab soravtansine) so that eligible Canadians can access the first meaningful new treatment for ovarian cancer in a decade.

This therapy represents a crucial advancement for women with FRα-positive, platinum-resistant ovarian cancer, offering a new personalized treatment option where very few exist. For women with this type of cancer, standard chemotherapy is no longer effective, and ELAHERE can give them hope.

Breakthroughs don’t happen when a treatment is discovered; they happen when patients can access it.

🔗 Join us and share your voice today: https://ovariancanada.org/advocate-volunteer/share-your-voice?utm_source=fb&utm_medium=social&utm_campaign=elahere&utm_content=makeaccesspossible

You’re not alone. Connect with others who may have similar stories on OVdialogue, our online peer support community. “De...
07/21/2026

You’re not alone. Connect with others who may have similar stories on OVdialogue, our online peer support community.

“Despite the challenges we face, the platform has a positive energy, and this community is incredibly supportive,” a user shares.

Active and available 24/7, you can connect for information, experience sharing, advice and encouragement. This discussion board is moderated and available anytime, anywhere.

Explore the community today: https://ovdialogue.ovariancanada.org/home

Part III of III: Kristine’s storyWe've covered what biomarkers are and why they're important. Now hear from someone who ...
07/10/2026

Part III of III: Kristine’s story

We've covered what biomarkers are and why they're important. Now hear from someone who experienced biomarker testing firsthand.

By the time someone is offered biomarker testing, they're often already navigating an overwhelming amount of information. For Kristine, that was certainly true.

When Kristine was diagnosed with ovarian cancer in 2024, her focus was simple: to get through surgery and get through chemotherapy.

"I felt like I was suddenly expected to understand this whole new world of information... everything all at once."

As part of her care, Kristine was offered biomarker testing. She met with a genetic counsellor who explained the testing process, what the results could mean, and answered her questions. After her initial testing, her oncologist also recommended HRD testing to provide additional information that could help guide her treatment plan.

In Kristine's case, the test results did not change her treatment. But having that information gave both her and her healthcare team greater confidence in the decisions they were making.

"I've come to appreciate that knowledge doesn't change the diagnosis – it can, however, change how you experience the journey."

Every person's experience is different, and biomarker testing won't affect everyone's treatment. But for many people, it can provide valuable information that helps inform care and supports informed decision-making.

➡ Learn more about biomarkers and how testing can support you as you navigate each stage of living with ovarian or endometrial cancer: https://ovariancanada.org/what-are-biomarkers

Address

4211 Yonge Street #316
North York, ON
M2P2A9

Alerts

Be the first to know and let us send you an email when Ovarian Cancer Canada posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share